• 1. Aggregation-induced emission enhancement in halochalcones?
  Patricia A. A. M. Vaz,Jo?o Rocha,Artur M. S. Silva New J. Chem., 2016,40, 8198-8201
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Recent Advances in the Study of Ethyl 3-(4-biphenyl)-3-oxopropanoate (CAS: 57477-98-2) and Its Applications in Chemical Biology and Pharmaceutical Research

Ethyl 3-(4-biphenyl)-3-oxopropanoate (CAS: 57477-98-2) is a β-keto ester derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including non-steroidal anti-inflammatory drugs (NSAIDs) and other pharmacologically active agents. Recent studies have explored its potential as a building block for the development of novel therapeutic compounds, particularly in the fields of oncology and inflammation.

One of the most notable advancements in the study of Ethyl 3-(4-biphenyl)-3-oxopropanoate is its role in the synthesis of biphenyl-based derivatives, which exhibit promising anti-inflammatory and anticancer properties. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound could selectively inhibit cyclooxygenase-2 (COX-2), an enzyme implicated in inflammatory processes and cancer progression. The researchers utilized molecular docking and in vitro assays to validate the compound's efficacy, highlighting its potential as a lead structure for further drug development.

In addition to its pharmacological applications, Ethyl 3-(4-biphenyl)-3-oxopropanoate has also been investigated for its utility in chemical biology. A recent study in ACS Chemical Biology (2024) reported the use of this compound as a fluorescent probe for detecting reactive oxygen species (ROS) in cellular environments. The study revealed that the compound's unique chemical structure allows for selective interaction with ROS, making it a valuable tool for studying oxidative stress-related diseases such as neurodegenerative disorders and cancer.

Another area of active research involves the optimization of synthetic routes for Ethyl 3-(4-biphenyl)-3-oxopropanoate. A 2024 publication in Organic Process Research & Development detailed a novel, scalable synthesis method that improves yield and reduces environmental impact. The study emphasized the importance of green chemistry principles in the production of such intermediates, which aligns with the growing demand for sustainable pharmaceutical manufacturing practices.

Despite these advancements, challenges remain in the clinical translation of Ethyl 3-(4-biphenyl)-3-oxopropanoate-derived compounds. Issues such as bioavailability, metabolic stability, and potential off-target effects require further investigation. Ongoing research aims to address these limitations through structural modifications and advanced formulation strategies. For instance, a 2023 study in European Journal of Pharmaceutical Sciences explored the use of nanotechnology-based delivery systems to enhance the compound's therapeutic efficacy.

In conclusion, Ethyl 3-(4-biphenyl)-3-oxopropanoate (CAS: 57477-98-2) continues to be a focal point of research in chemical biology and pharmaceutical sciences. Its multifaceted applications—from drug development to chemical probes—underscore its significance in advancing both fundamental and translational research. Future studies will likely focus on overcoming existing challenges and expanding its utility in emerging therapeutic areas.

• 677326-79-3(ethyl 3-(3-biphenyl)-3-oxopropanoate)
• 27835-00-3(ethyl 3-(4-methylphenyl)-3-oxopropanoate)
• 33166-79-9(Ethyl 3-oxo-3-(m-tolyl)propanoate)
• 54441-64-4(3-Oxo-3-phenylpropanoic acid butyl ester)
• 56216-10-5(Methyl 3-Biphenyl-4-yl-3-oxopropanoate)
• 138247-17-3(Ethyl 5-(4-biphenyl)-5-oxovalerate)
• 94-02-0(Ethyl benzoylacetate)
• 93-94-7(1,4-Benzenedipropanoicacid, b1,b4-dioxo-, 1,4-diethyl ester)
• 54441-63-3(Benzenepropanoic acid, beta-oxo-, propyl ester)
• 51725-80-5(3-(4-ETHYL-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER)